Kingdon Capital Management »

Soleno Therapeutics shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 575k 33.48
2025-12-31 $19M 400k 46.30
2025-09-30 $20M 301k 67.60

More positions owned by Kingdon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
NVIDIA Corporation (NVDA)
Nexgen Energy (NXE)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Msci Sth Kor Etf (EWY)
Keysight Technologies (KEYS)
Warby Parker Cl A Com (WRBY)
Soleno Therapeutics (SLNO)
Api Group Corp Com Stk (APG)
Maplebear (CART)
Howmet Aerospace (HWM)
Ishares Tr Msci Usa Mmentm Put Option (MTUM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Everus Constr Group (ECG)

View all positions for Kingdon Capital Management

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Wellington Management Company
Vanguard Group
venBio Select Advisor
State Street Corporation
Nantahala Capital Management
Vanguard Capital Management
Khrom Capital Management
Geode Capital Management
Polar Capital Holdings
Woodline Partners
Deep Track Capital
Braidwell

View all funds holding Soleno Therapeutics